Evidence map›Paper›PMID 37375271›Full record

ArticleMolecules (Basel, Switzerland)2023

Cytotoxic Compounds from

Ya-Ping Guo, Peng Yi, Qi-Qi Shi, Rui-Rui Yu, Jin-Hui Wang, Chen-Yang Li, Hai-Qiang Wu

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Molecules (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Heliyon · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Ya-Ping GuoGuangdong Key Laboratory for Biomedical Measurements and Ultrasound Imaging, National-Regional Key Technology Engineering Laboratory for Medical Ultrasound, School of Biomedical Engineering, Shenzhen University Medical School, Shenzhen 518060, China.ORCID 0000-0003-3733-0479
Peng YiSchool of Pharmaceutical Sciences, Shenzhen University Medical School, Shenzhen 518060, China.
Qi-Qi ShiSchool of Pharmaceutical Sciences, Shenzhen University Medical School, Shenzhen 518060, China.
Rui-Rui YuSchool of Pharmaceutical Sciences, Shenzhen University Medical School, Shenzhen 518060, China.
Jin-Hui WangSchool of Pharmacy, Harbin Medical University, Harbin 150081, China.
Chen-Yang LiGuangdong Key Laboratory for Biomedical Measurements and Ultrasound Imaging, National-Regional Key Technology Engineering Laboratory for Medical Ultrasound, School of Biomedical Engineering, Shenzhen University Medical School, Shenzhen 518060, China.
Hai-Qiang WuGuangdong Key Laboratory for Biomedical Measurements and Ultrasound Imaging, National-Regional Key Technology Engineering Laboratory for Medical Ultrasound, School of Biomedical Engineering, Shenzhen University Medical School, Shenzhen 518060, China.

Funding

Guangdong Basic and Applied Basic Research Foundation 2019B1515120029Shenzhen Natural Science Fund (the Stable Support Plan Program) 20220811110339002Shenzhen Science and Technology Innovation Committee JCYJ20190808122213241
6 · The paper itself

Abstract

Four compounds (

Indexed as

Antineoplastic AgentsBreast NeoplasmsIris PlantTriple Negative Breast NeoplasmsApoptosisCell Cycle CheckpointsCell Line, TumorCell ProliferationFemaleHumansAntineoplastic AgentsapoptosisBelamcanda chinensisiridal-type triterpenoidstriple-negative breast cancer

Identifiers

PMID37375271
PMCPMC10305019

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.